Skip to main content
VulnerabilityPublished

CVE-2026-80337: HAVELSAN Inc · Missing Authorization Vulnerability

Source GCVE Database

0
Compare
Authoritative record:CVE-2026-80337· Medium 5.3

Not known to be exploited · CVSS 5.3 Medium : upgrade to 2.1 when convenient.

Data as of 16 Nov 2026, 20:25 UTC

CVSS 3.1 base score
5.3Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.2% chance of exploitation in 30 days – higher than 11% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 2.1
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 2 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.

What to do

Upgrade Sef – AI Chatbot Platform to 2.1.

Affected software

ProductAffectedFixed in
HAVELSAN Inc.Sef - AI Chatbot PlatformAffected
  • <2.1
Fixed in
  • 2.1

AI-suggested

If you cannot patch yet, restrict access to the affected platform and monitor for unusual access patterns related to sensitive functionality.

Description

CVE-2026-80337 is a Missing Authorization vulnerability in HAVELSAN Inc.'s Sef - AI Chatbot Platform that allows access to functionality not properly constrained by access control lists (ACLs). This affects versions before 2.1. The vulnerability has a CVSS 3.1 base score of 5.3 (medium severity) with network attack vector, high attack complexity, low privileges required, no user interaction, and impacts confidentiality but not integrity or availability.

References

Community reviews

Loading reviews…